ENZON PHARMACEUTICALS INC (ENZN)

Overview Price 7.65 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank N/A - N/A Open Price $0.00 Previous Close $7.65 Daily Range $0.00 - $0.00 52-Week Range $6.13 - $11.82 Volume 0 Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases. Enzon's specialized sales force markets ABELCET, ONCASPAR, ADAGEN, and DEPOCYT in the United States. In addition, Enzon also receives royalties on sales of PEG-INTRON, marketed by Schering-Plough Corporation, and MACUGEN, marketed by OSI Pharmaceuticals and Pfizer Inc. Enzon's product-driven strategy includes an extensive drug development program that leverages its proprietary technologies, including a Customized Linker Technology PEGylation platform that utilizes customized linkers designed to release compounds at a controlled rate. Enzon also utilizes contract manufacturing opportunities to broaden its revenue base and enhance its organizational productivity. Enzon complements its internal research and development efforts with strategic initiatives. Other Resources for ENZN Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Enzon Plans a 50% Workforce Cut September 26, 2011 Zacks Blog: The Zacks Analyst Blog Highlights: Enzon Pharmaceuticals, Merck, Pfizer, UCB Pharma and Eastman Chemical Company September 13, 2011 Zacks Blog: Enzon Downgraded to Sell September 12, 2011 Zacks Blog: Weak Top Line Widens Enzon Loss August 9, 2011 Zacks Blog: Weak Top Line Widens Enzon Loss August 9, 2011 Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases. Enzon's specialized sales force markets ABELCET, ONCASPAR, ADAGEN, and DEPOCYT in the United States. In addition, Enzon also receives royalties on sales of PEG-INTRON, marketed by Schering-Plough Corporation, and MACUGEN, marketed by OSI Pharmaceuticals and Pfizer Inc. Enzon's product-driven strategy includes an extensive drug development program that leverages its proprietary technologies, including a Customized Linker Technology PEGylation platform that utilizes customized linkers designed to release compounds at a controlled rate. Enzon also utilizes contract manufacturing opportunities to broaden its revenue base and enhance its organizational productivity. Enzon complements its internal research and development efforts with strategic initiatives.   No brokerage coverage for ENZN   ENZN Ratings: BUY  SELL  HOLD ENZN Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 10 Buy 1 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	09/26/11	Enzon Plans a 50% Workforce Cut - Analyst Blog	0
Zacks_Analysts	0.00	09/12/11	Enzon Downgraded to Sell - Analyst Blog	0
Zacks_Analysts	0.00	08/09/11	Weak Top Line Widens Enzon Loss - Analyst Blog	0
Zacks_Analysts	0.00	05/23/11	Enzon Stops Colorectal Cancer Study - Analyst Blog	0
Zacks_Analysts	0.00	05/11/11	Enzon Trims Loss on Cost Cuts - Analyst Blog	0
Zacks_Analysts	0.00	04/04/11	Enzon Still at Neutral - Analyst Blog	0
Zacks_Analysts	0.00	02/22/11	Enzon Cuts Losses, Misses Zacks - Analyst Blog	0
Zacks_Analysts	0.00	01/06/11	Enzon Pharm Upped to Neutral - Analyst Blog	0
Zacks_Analysts	0.00	01/05/11	Pfizer Expands Santaris Agreement - Analyst Blog	0
Zacks_Analysts	0.00	11/15/10	Enzon Cut to Underperform - Analyst Blog	0

Pages: [ 1 ]  2  >>

Commentary

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $7.30 Points: +12.73 Created: 01/01/2008 Comments: 0 | Comment MikeM Recs:

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $7.25 Points: +13.45 Created: 01/01/2008 Comments: 0 | Comment giorgiopeterlongo Recs:

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $6.91 Points: +18.64 Created: 01/01/2008 Comments: 0 | Comment ELD24 Recs:

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $6.83 Points: +19.94 Created: 01/01/2008 Comments: 0 | Comment shaminator Recs:

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $7.22 Points: +13.89 Created: 01/01/2008 Comments: 0 | Comment dinbigd Recs:

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $7.32 Points: +12.44 Created: 01/01/2008 Comments: 0 | Comment oknad Recs:

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $8.95 Points: -6.59 Created: 01/01/2008 Comments: 0 | Comment Wizard99 Recs:

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $8.55 Points: -2.60 Created: 01/01/2008 Comments: 0 | Comment amccltjim Recs:

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $8.10 Points: +2.38 Created: 01/01/2008 Comments: 0 | Comment Sully Recs:

BUY: ENZON PHARMACEUTICALS INC. (ENZN) Start Price: $8.24 Points: +0.73 Created: 01/01/2008 Comments: 0 | Comment seven Recs:

Pages: [ 1 ]  2  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
MikeM	53.54	BUY	Six Months to a Year	01/01/2008	$7.30	$7.65 (-0.90%)	+4.81%	-7.92%	+12.73
giorgiopeterlongo	32.52	BUY	Six Months to a Year	01/01/2008	$7.25	$7.65 (-0.90%)	+5.53%	-7.92%	+13.45
ELD24	57.55	BUY	Six Months to a Year	01/01/2008	$6.91	$7.65 (-0.90%)	+10.72%	-7.92%	+18.64
shaminator	31.41	BUY	Six Months to a Year	01/01/2008	$6.83	$7.65 (-0.90%)	+12.02%	-7.92%	+19.94
dinbigd		BUY	Six Months to a Year	01/01/2008	$7.22	$7.65 (-0.90%)	+5.97%	-7.92%	+13.89
oknad	32.52	BUY	Six Months to a Year	01/01/2008	$7.32	$7.65 (-0.90%)	+4.52%	-7.92%	+12.44
Wizard99	53.45	BUY	Six Months to a Year	01/01/2008	$8.95	$7.65 (-0.90%)	-14.52%	-7.92%	-6.59
amccltjim	72.43	BUY	Six Months to a Year	01/01/2008	$8.55	$7.65 (-0.90%)	-10.52%	-7.92%	-2.60
Sully	53.45	BUY	Six Months to a Year	01/01/2008	$8.10	$7.65 (-0.90%)	-5.55%	-7.92%	+2.38
seven	72.43	BUY	Six Months to a Year	01/01/2008	$8.24	$7.65 (-0.90%)	-7.19%	-7.92%	+0.73

Pages: [ 1 ]  2  >>